期刊文献+

伴有低钠血症的心力衰竭的治疗进展 被引量:13

Treatment advances in congestive heart failure associated with hyponatremia
下载PDF
导出
摘要 心力衰竭时的低钠血症是一种高容量性稀释性低钠血症,其发生机制与心输出量减少,使血管升压素分泌增加,使肾小管对水的重吸收增加所致。常规治疗方法疗效不佳。血管升压素受体拮抗药是伴有低钠血症的心力衰竭治疗的最有效方法。 Hyponatremia in congestive heart failure is a hypervolemic (dilutional) hyponatremia. Its mechanism is related to decreased cardiac output, increased arginine vasopressin release and increased water reabsorption in the renal collecting ducts. The conventional treatments are unsatisfactory. Arginine vasopressin receptor antagonist is the most effective treatment for congestive heart failure associated with hyponatremia.
作者 黄震华
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2008年第5期384-387,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 心力衰竭 充血性 低钠血症 治疗 血管升压素 heart failure, congestive hyponatremia therapy arginine vasopressin
  • 相关文献

参考文献14

  • 1OREN RM. Hyponatremia in congestive heart failure[J]. Am J Cardiol, 2005, 95(9A) : 2B-7B. 被引量:1
  • 2ADROGUE HJ, MADIAS NE. Hyponatremia[J]. N Engl J Med, 2000, 342(21) : 1581-1589. 被引量:1
  • 3LEE CR, WATKINS ML, PATTERSON JH, et al. Vasopressin:a new target for the treatment of heart failure[J]. Am Heart J, 2003, 146(1): 9-18. 被引量:1
  • 4CHEN MC, CHANG HW, CHENG CI, et al. Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy[J]. Cardiology, 2003, 100(3): 136-142. 被引量:1
  • 5GOLDSMITH SR. Current treatment and novel pharmacologic treatments for hyponatremia in congestive heart failure[J]. Am J Cardiol, 2005, 95(9A): 14B-23B. 被引量:1
  • 6LICATA G, DI PASQUALE P, PARRINELLO G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects[J]. Am Heart J, 2003, 145(3): 459-466. 被引量:1
  • 7HIRANO T, YAMAMURA Y, NAKAMURA S, et al. Effects of the V2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats[J]. J Pharmacol Exp Ther, 2000, 292(1): 288-294. 被引量:1
  • 8CHATTERJEE K, Neurohormonal activation in congestive heart failure and the role of vasopressin[J]. Am J Cardiol, 2005, 95 (9A) : 8B-13B. 被引量:1
  • 9THIBONNIER M. Vasopressin receptor antagonists in heart failure [J]. Curr Opin Pharmacol, 2003, 3(6) : 683-687. 被引量:1
  • 10GHEORGHIADE M, NIAZI I, OUYANG J, et al. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial[J]. Circulation, 2003, 107(21): 2690-2696. 被引量:1

同被引文献124

引证文献13

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部